Biomarin Pharmaceutical reported $1.08B in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 182.44M 3.77M
Agios Pharmaceuticals AGIO:US $ 0.53M 0.08M
Alnylam Pharmaceuticals ALNY:US $ 676.71M 1.01M
Amgen AMGN:US $ 36854M 3545M
Bayer BAYN:GR € 42547M 1675M
Biogen BIIB:US $ 7275.2M 2.1M
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Bluebird Bio BLUE:US $ 0M 0M
Gilead Sciences GILD:US $ 26208M 487M
Insmed INSM:US $ 806.79M 225.49M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
IONIS PHARMACEUT IONS:US $ 1252.14M 23.19M
Moderna Inc MRNA:US 806M 42M
Neurocrine Biosciences NBIX:US $ 377.7M 42.6M
Ptc Therapeutics PTCT:US $ 1197.09M 8.62M
Puma Biotechnology PBYI:US $ 97.38M 0.29M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 0.7M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.98M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
YTE INCY:US $ 34.18M 0.09M